Veru Inc.
VERU- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000863894
No open-market purchases or sales by Veru Inc. insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q3 2026, worth $6.92M in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 19, 2026
- $36.0M
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ3 2026, −4 vs. previous quarter
- 56
- 13F valueReported value at the end of Q3 2026
- $6.92M
- Superinvestors holdingAt the end of Q3 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- –
- No comparable prior period
- Net income, FY2025
- -$22.7M
- No comparable prior period
- Free cash flow, FY2025
- -$30.0M
- No comparable prior period
- Revenue, Q3 FY2026
- –
- No comparable prior period
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 1.50M
- Shares sold short
- Change
- +33.6K
- +2.3% vs. previous
- Days to cover
- 13.25
- At average daily volume
Superinvestors holding VERU, Q3 2026
Go to the superinvestors tabNo superinvestor reported holding VERU at the end of Q3 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Veru Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2026 (view filing)4:26 PM ET | Aug 13 | 4 days | Barnette K GaryChief Scientific Officer | PPurchase | +1.80K | $2.69 | +$4.84K | +360.0%2.30K after | |
| Feb 20, 2025 (view filing) | Feb 18-19 | 2 days | Rankowitz Michael LDirector | PPurchase | +150.0K | $0.5609 | +$84.1K | +150.0%250.0K after | 2 lots |
| May 28, 2024 (view filing) | May 24 | 4 days | Fisch HarryChief Corporate Officer | PPurchase | +4.00K | $1.25 | +$5.00K | +0.5%774.7K after | |
| May 24, 2024 (view filing) | May 24 | Same day | Barnette K GaryChief Scientific Officer | PPurchase | +5.00K | $1.34 | +$6.70K | New position5.00K after | |
| May 24, 2024 (view filing) | May 22-24 | 2 days | Steiner Mitchell ShusterPresident and CEO | SSale | −70.2K | $1.25 | −$87.4K | −1.0%6.94M after | 3 lots |
| May 17, 2024 (view filing) | May 15 | 2 days | Fisch HarryChief Corporate Officer | PPurchase | +6.71K | $1.49 | +$10.0K | +0.9%770.7K after | |
| May 17, 2024 (view filing) | May 15-17 | 2 days | Steiner Mitchell ShusterPresident and CEO | SSale | −171.9K | $1.44 | −$247.4K | −2.4%7.01M after | 3 lots |
| Aug 17, 2022 (view filing) | Aug 15 | 2 days | Eisenberger MarioDirector | SSale | −100.0K | $20.04 | −$2.00M | −100.0%0 after | |
| Aug 19, 2021 (view filing) | Aug 17 | 2 days | Lu LucyDirector | PPurchase | +4.80K | $6.78 | +$32.5K | +96.0%9.80K after |
Top 10 13F holders, Q3 2026
See all 56 holdersThe largest institutional positions in Veru Inc. at the end of Q3 2026; share changes are against Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 690,105 | $1.84M | 0.00% | −8,334−1.2% | Reduced |
| Renaissance Technologies LLC | 207,450 | $551.8K | 0.00% | +43,000+26.1% | Added |
| Oppenheimer & Co Inc | 196,547 | $522.8K | 0.01% | −14,296−6.8% | Reduced |
| Geode Capital Management, LLC | 194,231 | $516.8K | 0.00% | +39,155+25.2% | Added |
| BlackRock, Inc. | 164,802 | $438.4K | 0.00% | −2,282−1.4% | Reduced |
| Summit Financial, LLC | 140,955 | $374.9K | 0.00% | −910−0.6% | Reduced |
| Gsa Capital Partners LLP | 129,431 | $344.0K | 0.02% | −27,905−17.7% | Reduced |
| Schonfeld Strategic Advisors LLC | 88,798 | $236.2K | 0.00% | +88,798 | New |
| Raymond James Financial Inc | 81,872 | $217.8K | 0.00% | −3,097−3.6% | Reduced |
| Vanguard Fiduciary Trust Co | 81,230 | $216.1K | 0.00% | 00.0% | Unchanged |
Holders of 5% or more of VERU
See all 1 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Veru Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Alyeska Investment Group, L.P. | 13G | 9.90%1.59M shares | New | Feb 17, 20261 filing | Feb 17, 2026 | SEC |